Network Pharmacology and Docking of Nephrolepis cordifolia as Type-2 Antidiabetic Agent
Article Sidebar
Main Article Content
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by disturbances in insulin secretion or action. Impaired insulin secretion causes blood glucose to increase continuously, resulting in potential complications of the disease, such as diabetic neuropathy, coronary heart disease, and hypertension. Therefore, this study aims to identify compounds from N. cordifolia with potential for T2DM and their mechanisms using network pharmacology and docking. The screening results showed that ellagic acid was the active compound with the potential to bind to T2DM proteins. Ellagic acid also helped in the treatment of T2DM by interacting with PI3K-Akt, Rap1, mTOR signalling, endocrine resistance, focal adhesion, and FOXO signalling. Based on the docking of ellagic acid against the FOXO signalling protein, namely; CDK2, EGFR, INSR; SMAD3, IGF1; BRAF, AKT1, and IGF1R, the binding energy values obtained were -8.56; -7.77; -7.43; -7.05; -7.68; -6.48; -7.82; -8.9 kcal/mol, respectively. This indicates that ellagic acid had a strong binding affinity with the target protein. In conclusion, ellagic acid was identified as a major compound from N. cordifolia that could be used to treat T2DM by alteration of FOXO signalling.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Bhutkar M, Bhinge S, Randive D, Wadkar G, Todkar S. Studies on Glucose Adsorption Capacity of Some Indigenous Plants. Glob J Pharm Pharm Sci. 2018;5(1):1–4.
Cura JK, Basilio A, Llagas MCD Las. Antidiabetic, anti-inflammatory and cytotoxic potential of Theobroma cacao Linn. husk aqueous extracts. Clin Phytosci. 2021; 7(1):1–7.
Wahyuni T. Antioxidant Potential of Ethanol Extract of Starfruit Leaves (Averrhoa Bilimbi L.) and Its Effect on Blood Sugar Levels in Male Wistar Rats Induced by Streptozotocin. Inpharnmed J. 2021; 27:5:9.
Rehman G, Hamayun M, Iqbal A, Ul Islam S, Arshad S, Zaman K, Ahmad A, Shehzad A, Hussain A, Lee I. In vitro antidiabetic effects and antioxidant potential of Cassia nemophila pods. Biomed Res Int. 2018; 2018(1):1824790.
Shakya AK. Medicinal plants : Future Source of New Drugs. Int J Herb Med. 2016; 4:59–64.
Adlini M, Hartono A, Khairani M, Tanjung I, Khairuna K. Identification of Ferns (Pteridophyta) at the State Islamic University (UIN) of North Sumatra. Biota J Ilm Ilmu-Ilmu Hayati. 2021; 10:87–94.
Singh M, Singh N, Khare PB, Rawat AKS. Antimicrobial activity of some important Adiantum species used traditionally in indigenous systems of medicine. J Ethnopharmacol. 2008; 115(2):327–329.
Liang ZY, Yang XS, Zhu HY, Hao XJ. Chemical constituents of Nephrolepis cordifolia. China Natl Knowl Infrastructure Guihaia. 2008. 3 p.
El-Tantawy ME, Shams MM, Afifi MS. Chemical composition and biological evaluation of the volatile constituents from the aerial parts of Nephrolepis exaltata (L.) and Nephrolepis cordifolia (L.) C. Presl grown in Egypt. Nat Prod Res. 2016; 30(10):1197–201.
Rani D, Khare PB, Dantu PK. In Vitro Antibacterial and Antifungal Properties of Aqueous and Non-Aqueous Frond Extracts of Psilotum nudum, Nephrolepis biserrata and Nephrolepis cordifolia. Indian J Pharm Sci. 2010; 72(6):818–822.
Jaishee N, Lama R, Chakraborty U. Evaluation of antimicrobial activity and HPLC analysis of phenolics present in Nephrolepis cordifolia (l.) C. (Persl). J Mycopathol Res. 2021; 59(1):37–45.
Hadi S, Subekti A, Khairunnisa A. Antioxidant Test and Flavonoids Determination of Tuber Pakis Kinca (Nephrolepis cordifolia (L) C. Presl). Indones J Chem Anal. 2023; 6(1):1–9.
Dal S, Sigrist S. The protective effect of antioxidants consumption on diabetes and vascular complications. Dis (Basel, Switzerland). 2016; 4(3): 24.
Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord. 2013; 12(1):43.
Rajeshekar U, Swamy BM, Jayaveera KN. Hepatoprotective activity of hydro-alcoholic extract of whole plant of Solanum dulcamara L. and
Nephrolepis cordifolia (L) C. Presl against paracetamol induced hepatotoxicity in albino rats. Asian J Pharm Clin Res. 2015; 1(8):364–370.
Manimegalai P, Selvam K, Prakash P, Kirubakaran D, Shivakumar M, SenthilNathan S. In-vitro antibacterial, antioxidant and anti-inflammatory and In-silico ADMET, molecular docking study on Hardwickia binata phytocompunds with potential inhibitor of skin cancer protein. Silico Pharmacol. 2023; 23:11.
Pal R, Teli G, Sharma B, Kumar B, Chawla PA. In vitro anti-inflammatory and antioxidant activity of Nephrolepis cordifolia and molecular docking of its active chemical constituents. Pharmaspire. 2021; 13(1):21–27.
Sureshkumar J and Ayyanar M. Phytochemical Composition and in Vitro Antioxidant and Antidiabetic Activities of Nephrolepis auriculata (L.) Trimen: An Unexplored Ethnomedicinal Fern BT - Ferns: Biotechnology, Propagation, Medicinal Uses and Environmental Regulation. In: Marimuthu J, Fernández H, Kumar A, Thangaiah S, editors. Singapore: Springer Nature Singapore; 2022. 571–584 p.
Ojieh AE. Evaluation of Antidiabetic and Antioxidant Potential of Nephrolepis unduranta leaf extract in Streptozotocin-Induced Diabetic Wistar Rats. Int J Forensic Med Invest. 2020; 5(1):34–41.
Ossai N, Richard, Anthony E, Nwogueze BC, Olowe G, Eyituoyo A. Ameliorative Potentials of Methanolic Leaf Extract of Nephrolepis Undulate In Streptozotocin-Induced Diabetic Wistar Rats. Plant Cell Biotechnol Mol Biol. 2021; 1(22):41–53.
Chang CLT, Lin Y, Bartolome AP, Chen YC, Chiu SC, Yang WC. Herbal therapies for type 2 diabetes mellitus: chemistry, biology, and potential application of selected plants and compounds. Evid-Based Complement Alternat Med. 2013; 2013:378657.
Land H and Humble MS. YASARA: A Tool to obtain Structural Guidance in Biocatalytic Investigations. Methods Mol Biol. 2018; 1685:43–67.
Li X, Tang Q, Meng F, Du P, Chen W. INPUT: An intelligent network pharmacology platform unique to traditional Chinese medicine. Comput Struct Biotechnol J. 2022; 1(20):1345–1351.
Jiang LR, Qin Y, Nong JL, An H. Network Pharmacology analysis of pharmacological mechanisms underlying the anti-type 2 diabetes mellitus effect of guava leaf. Arab J Chem. 2021; 1(14):103143.
Gao X, Li S, Cong C, Wang Y, Xu L. A Network Pharmacology Approach to Estimate Potential Targets of the Active Ingredients of Epimedium for Alleviating Mild Cognitive Impairment and Treating Alzheimer’s Disease. Evid-Based Complement Alternat Med. 2021; 2021:2302680.
Wan Y, Xu L, Liu Z, Yang M, Jiang X, Zhang Q, & Huang, J. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms. BMC Complement Altern Med. 2019; 19(1):158.
Zhang L, Shi X, Huang Z, Mao J, Mei W, Ding L, Zhang, L., Xing, R., Wang, P. Network Pharmacology Approach to Uncover the Mechanism Governing the Effect of Radix Achyranthis Bidentatae on Osteoarthritis. BMC Complement Med Ther. 2020; 20(1):121.
Liu J, Zhang L, Wang Z, Chen S, Feng S, He Y, Zhang, S. Network Pharmacology-Based Strategy to Identify the Pharmacological Mechanisms of Pulsatilla Decoction against Crohn’s Disease. Front Pharmacol. 2022; 13:844685.
Liu K, Watanabe E, Kokubo H. Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations. J Comput Aided Mol Des. 2017; 31(2):201–211.
Falodun A, Siraj R, Choudhary M. GC-MS Analysis of Insecticidal Leaf Essential Oil of Pyrenacantha staudtii Hutch and Dalz (Icacinaceae). Trop J Pharm Res. 2009 Jul 22;8(2):139–143.
Rahim F, Putra PP, Ismed F, Putra AE, Lucida H. Molecular Dynamics, Docking and Prediction of Absorption, Distribution, Metabolism and Excretion of Lycopene as Protein Inhibitor of Bcl2 and DNMT1. Trop J Nat Prod Res. 2023; 7(7):3439–3444.
Nur S, Hanafi M, Setiawan H, Nursamsiar N, Elya B. Molecular Docking Simulation of Reported Phytochemical Compounds from Curculigo latifolia Extract on Target Proteins Related to Skin Antiaging. Trop J Nat Prod Res. 2023; 7(11):5067–5080.
Rahman H, Bintang MI, Asnawi A, Febrina E. Exploring the Molecular Interactions between Volatile Compounds in Coconut Shell Liquid Smoke and Human Bitter Taste TAS2R46 Based on the Molecular Docking and Molecular Dynamics. Trop J Nat Prod Res. 2023; 7(12):5587–5594.
Huang X, Liu G, Guo J, Su Z. The PI3K/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018; 14(11):1483–1496.
Cao R, Tian H, Zhang Y, Liu G, Xu H, Rao G, Tian, Y., & Fu, X. Signaling pathways and intervention for therapy of type 2 diabetes mellitus. MedComm. 2023; 4(3):e283.
Schultze SM, Hemmings BA, Niessen M, Tschopp O. PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev Mol Med. 2012; 14:e1.
Rondas D, Tomas A, Halban PA. Focal adhesion remodelling is crucial for glucose-stimulated insulin secretion and involves the activation of focal adhesion kinase and paxillin. Diabetes. 2011; 60(4):1146–1157.
Jin B, Wang J, Chen Y, Zuo W, Hong B, Li J, Huang, F., Zhang, M., & Wang, Y. Focal adhesion kinase induces cardiac remodeling through NF-κB-mediated inflammatory responses in diabetic cardiomyopathy. Int Immunopharmacol. 2023; 120:110280.
Lu Y, Li Y, Li G, Lu H. Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis. Mol Med Rep. 2020; 22(3):1868–1882.
Kaneko K, Lin HY, Fu Y, Saha PK, De la Puente-Gomez AB, Xu Y, Ohinata K, Chen P, Morozov A, Fukuda M. Rap1 in the VMH regulates glucose homeostasis. JCI Insight. 2021; 6(11): e146099.
Vanni R, Bussuan RM, Rombaldi RL, Arbex AK. Endocrine Disruptors and the Induction of Insulin Resistance. Curr Diabetes Rev. 2021; 17(7):e102220187107.
Ni Q, Song J, Wang Y, Sun J, Xie J, Zhang J, Ning, G., Wang W, Wang Q. Proper mTORC1 Activity Is Required for Glucose Sensing and Early Adaptation in Human Pancreatic β Cells. J Clin Endocrinol Metab. 2021; 106(2):e562–572.
Fryk E, Olausson J, Mossberg K, Strindberg L, Schmelz M, Brogren H, Gan L-M, Piazza S, Provenzani A, Becattini B, Lind L, Solinas G, Jansson P-A. Hyperinsulinemia and insulin resistance in the obese may develop as part of a homeostatic response to elevated free fatty acids: A mechanistic case-control and a population-based cohort study. EBioMed. 2021; 65:103264.
Teaney NA, Cyr NE. FoxO1 as a tissue-specific therapeutic target for type 2 diabetes. Front Endocrinol (Lausanne). 2023; 14:1286838.
Benchoula K, Arya A, Parhar IS, Hwa WE. FoxO1 signalling as a therapeutic target for type 2 diabetes and obesity. Eur J Pharmacol. 2021; 891:173758.
Calissi G, Lam EWF, Link W. Therapeutic strategies targeting FOXO transcription factors. Nat Rev Drug Discov. 2021; 20(1):21–38.
Naraki K, Ghasemzadeh Rahbardar M, Ajiboye BO, Hosseinzadeh H. The effect of ellagic acid on the metabolic syndrome: A review article. Heliyon. 2023; 9(11):e21844.
Lin Z, Tong Y, Li N, Zhu Z, Li J. Network pharmacology-based study of the mechanisms of action of anti-diabetic triterpenoids from Cyclocarya paliurus. RSC Adv. 2020; 10(61):37168–37181.
Buckley ME, Ndukwe ARN, Nair PC, Rana S, Fairfull-Smith KE, Gandhi NS. Comparative assessment of docking programs for docking and virtual screening of ribosomal oxazolidinone antibacterial agents. Antibiotics (Basel, Switzerland). 2023; 12(3): 492.